A Phase I, Randomized, Double-blind, Placebo-controlled Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples
During this study, participants will ingest 100 mg of fluorescein disodium or a placebo (no drug) mixed in GatoradeTM. Participants will then provide a urine sample after 10, 15, 20 or 30 minutes to see if the investigator can detect fluorescein fluorescence (light) in the urine.
100 Clinical Results associated with UpTru Inc.
0 Patents (Medical) associated with UpTru Inc.
100 Deals associated with UpTru Inc.
100 Translational Medicine associated with UpTru Inc.